Terms: = Head and neck cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Treatment
39 results:
1. Artificial intelligence-based diagnosis of the depth of laryngopharyngeal cancer.
Yumii K; Ueda T; Kawahara D; Chikuie N; Taruya T; Hamamoto T; Takeno S
Auris Nasus Larynx; 2024 Apr; 51(2):417-424. PubMed ID: 37838567
[TBL] [Abstract] [Full Text] [Related]
2. Nutritional intervention for the prognosis of nasopharyngeal carcinoma chemoradiotherapy patients: A meta-analysis.
He Y; Chen X; Yang T; Li Y; Tan S; Liu X
Medicine (Baltimore); 2023 Oct; 102(41):e35386. PubMed ID: 37832079
[TBL] [Abstract] [Full Text] [Related]
3. Patterns of care amongst older adults diagnosed with locally advanced esophageal cancer: A cohort study.
Gaber CE; Shaheen NJ; Sandler RS; Edwards JK; Nichols HB; Sanoff HK; Lund JL
J Geriatr Oncol; 2022 Nov; 13(8):1178-1187. PubMed ID: 36008272
[TBL] [Abstract] [Full Text] [Related]
4. Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcinoma: Propensity Score-matched Analysis From 85 Authorized Institutes for Esophageal cancer in Japan.
Matsuda S; Kitagawa Y; Takemura R; Okui J; Okamura A; Kawakubo H; Muto M; Kakeji Y; Takeuchi H; Watanabe M; Doki Y
Ann Surg; 2023 Jul; 278(1):e35-e42. PubMed ID: 35837977
[TBL] [Abstract] [Full Text] [Related]
5. Effect of Hospital Safety Net Burden on Survival for Patients With Sinonasal Squamous Cell Carcinoma.
Tseng CC; Gao J; Barinsky GL; Fang CH; Grube JG; Patel P; Hsueh WD; Eloy JA
Otolaryngol Head Neck Surg; 2023 Mar; 168(3):413-421. PubMed ID: 35608906
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes in surgical management of sinonasal malignancy-A single comprehensive cancer center experience.
Adilbay D; Valero C; Fitzgerald C; Yuan A; Mimica X; Gupta P; Wong RJ; Shah JP; Patel SG; Ganly I; Cohen MA
Head Neck; 2022 Apr; 44(4):933-942. PubMed ID: 35080076
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study).
Yang Y; Zhou T; Chen X; Li J; Pan J; He X; Lin L; Shi YR; Feng W; Xiong J; Yang K; Yu Q; Zhang Q; Hu D; Sun Y; Hu G; Li P; Shen L; Lin Q; Zhang B; Qu X; Zou J; Zhang L; Fang W; Zhao Y
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34933967
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic factors for incomplete response in thyroid microcarcinoma: an analysis of initial response to therapy in 517 patients.
Faro FN; Simões VRF; Ricardo GP; Cabral CP; de Cássia Braga Ribeiro K; Scalissi NM; Cury AN; Marone MM; do Prado Padovani R; Ferraz C
Arch Endocrinol Metab; 2021 Oct; 65(5):579-587. PubMed ID: 33740337
[TBL] [Abstract] [Full Text] [Related]
9. Quality of Life Outcomes in Patients With Sinonasal Malignancy After Definitive treatment.
Philips R; Agarwal A; Chitguppi C; Swendseid B; Graf A; Murphy K; Jangro W; Rhodes L; Toskala E; Luginbuhl A; Curry J; Nyquist G; Rosen M; Johnson J; Rabinowitz M
Laryngoscope; 2021 Jul; 131(7):E2212-E2221. PubMed ID: 33368340
[TBL] [Abstract] [Full Text] [Related]
10. CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8
Braun M; Aguilera AR; Sundarrajan A; Corvino D; Stannard K; Krumeich S; Das I; Lima LG; Meza Guzman LG; Li K; Li R; Salim N; Jorge MV; Ham S; Kelly G; Vari F; Lepletier A; Raghavendra A; Pearson S; Madore J; Jacquelin S; Effern M; Quine B; Koufariotis LT; Casey M; Nakamura K; Seo EY; Hölzel M; Geyer M; Kristiansen G; Taheri T; Ahern E; Hughes BGM; Wilmott JS; Long GV; Scolyer RA; Batstone MD; Landsberg J; Dietrich D; Pop OT; Flatz L; Dougall WC; Veillette A; Nicholson SE; Möller A; Johnston RJ; Martinet L; Smyth MJ; Bald T
Immunity; 2020 Oct; 53(4):805-823.e15. PubMed ID: 33053330
[TBL] [Abstract] [Full Text] [Related]
11. [A comparative study on the efficacy of transoral vestibular approach, via bilateral areola approach endoscopic and open thyroidectomy on stage T1b papillary thyroid carcinoma].
Liu ZD; Li YJ; Yu X; Xiang C; Wang P; Wang Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Oct; 55(10):905-912. PubMed ID: 33036504
[No Abstract] [Full Text] [Related]
12. Early Diagnosis of Medullary Thyroid cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
13. Survival differences between definitive radiotherapy and surgery followed by adjuvant radiotherapy in supraglottic and hypopharyngeal carcinoma.
Zhang M; Gao XS; Qin Y; Sun Y; Ma MW
Chin Med J (Engl); 2019 Nov; 132(22):2698-2704. PubMed ID: 31765356
[TBL] [Abstract] [Full Text] [Related]
14. The Transareola Endoscopic Approach Yields Adequate Oncological Dissection as Open Approach in the treatment of Papillary Thyroid Carcinoma.
Gao H; Chen C; Liu X; Xu N; Wang Y; Qu R; Yu X
Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):489-492. PubMed ID: 31584497
[TBL] [Abstract] [Full Text] [Related]
15. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.
Liu M; Liu Z; Liu F; Guo C; Xu R; Li F; Liu A; Yang H; Zhang S; Shen L; Duan L; Wu Q; Cao C; Pan Y; Liu Y; Li J; Cai H; He Z; Ke Y
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1626-1635.e7. PubMed ID: 31518715
[TBL] [Abstract] [Full Text] [Related]
16. [
Chen S; Li Z; Zhou L; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):554-560. PubMed ID: 31140419
[TBL] [Abstract] [Full Text] [Related]
17. Multicenter Trial of [
Lowe VJ; Duan F; Subramaniam RM; Sicks JD; Romanoff J; Bartel T; Yu JQM; Nussenbaum B; Richmon J; Arnold CD; Cognetti D; Stack BC
J Clin Oncol; 2019 Jul; 37(20):1704-1712. PubMed ID: 30768363
[TBL] [Abstract] [Full Text] [Related]
18. Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways.
Zimmaro LA; Sephton SE; Siwik CJ; Phillips KM; Rebholz WN; Kraemer HC; Giese-Davis J; Wilson L; Bumpous JM; Cash ED
Cancer; 2018 Mar; 124(5):1053-1060. PubMed ID: 29355901
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
[TBL] [Abstract] [Full Text] [Related]
20. Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification.
Ooft ML; van Ipenburg J; van Loo R; de Jong R; Moelans C; Braunius W; de Bree R; van Diest P; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
J Clin Pathol; 2018 Apr; 71(4):351-359. PubMed ID: 28893862
[TBL] [Abstract] [Full Text] [Related]
[Next]
